SCHEMBL6319490

SCHEMBL6319490

Cc1c(-c2ccccc2)c(N2C[C@H](CO)[C@H](N(C)C)C2)n2c(nc3ccccc32)c1C#N

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.47
KDM4E B2RXH2 7/20 0.47
GAA P10253 4/20 0.47
RXFP1 Q9HBX9 3/20 0.47
GLA P06280 3/20 0.47
LMNA P02545 5/20 0.46
NPSR1 Q6W5P4 4/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
RECQL P46063 1/20 0.46
TSHR P16473 3/20 0.46
NCOA3 Q9Y6Q9 1/20 0.45
CASP1 P29466 3/20 0.44
CASP7 P55210 2/20 0.44
HPGD P15428 2/20 0.44
HSD17B10 Q99714 2/20 0.44
MAPK1 P28482 2/20 0.43
PKM P14618 1/20 0.43
MAPT P10636 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6320383 0.86 ALDH1A1 (0.51) ALDH1A1KDM4EGAARXFP1GLA
SCHEMBL6320385 0.81 ALDH1A1 (0.52) ALDH1A1KDM4EGAARXFP1GLA
SCHEMBL6311650 0.80 ALDH1A1 (0.49) ALDH1A1KDM4EGAARXFP1GLA
SCHEMBL6310690 0.79 ALDH1A1 (0.46) ALDH1A1KDM4EGAARXFP1GLA
Formic Acid SCHEMBL6310674 0.79 ALDH1A1 (0.46) ALDH1A1KDM4EGAARXFP1GLA
SCHEMBL6317936 0.78 ALDH1A1 (0.55) ALDH1A1KDM4EGAARXFP1GLA
SCHEMBL6311934 0.77 ALDH1A1 (0.47) ALDH1A1KDM4EGAARXFP1GLA
SCHEMBL6310825 0.77 ALDH1A1 (0.52) ALDH1A1KDM4EGAARXFP1GLA
SCHEMBL6309923 0.77 ALDH1A1 (0.48) ALDH1A1KDM4EGAARXFP1GLA
SCHEMBL6310584 0.77 ALDH1A1 (0.47) ALDH1A1KDM4EGAARXFP1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-05-26 US disclosed
EP-1479681-A1 IMIDAZO(1,2-a)PYRIDINE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative MANBA, MAN2B1, ERG28 ALDH1A1 2550/4885KDM4E 3360/4885GAA 58/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.